|
Volumn 57, Issue 2, 1996, Pages 173-176
|
Concurrent alpha1 adrenergic blockade and angiotensin converting enzyme inhibition in the treatment of congestive heart failure
a a a |
Author keywords
congestive heart failure; enalapril prazosin combination; exercise tolerance; renin angiotensin system; sympathetic nervous system
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
PRAZOSIN;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DRUG EFFICACY;
EXERCISE;
FEMALE;
HUMAN;
HYPOTENSION;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
ADMINISTRATION, ORAL;
ADRENERGIC ALPHA-ANTAGONISTS;
ADULT;
ANALYSIS OF VARIANCE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CONFIDENCE INTERVALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
ENALAPRIL;
EXERCISE TOLERANCE;
FEMALE;
HEART FAILURE, CONGESTIVE;
HEMODYNAMIC PROCESSES;
HUMANS;
MALE;
MIDDLE AGED;
PRAZOSIN;
TREATMENT OUTCOME;
|
EID: 0030573042
PISSN: 01675273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-5273(96)02799-4 Document Type: Article |
Times cited : (8)
|
References (5)
|